Predictions
Freelance.com
Start price
Target price
Perf. (%)
€6.21
18.10.22
18.10.22
€7.00
18.10.23
18.10.23
-48.07%
19.10.23
19.10.23
Could be worthwhile Investment >10% per year
Aveo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.70
18.10.22
18.10.22
-
18.10.23
18.10.23
0.78%
29.10.22
29.10.22
Capable Management
Probably not worthwhile Investment
Little innovation
Few uniques
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€12.20
18.10.22
18.10.22
-
18.10.23
18.10.23
72.13%
15.11.22
15.11.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
CropEnergies AG
Start price
Target price
Perf. (%)
€15.04
17.10.22
17.10.22
€25.00
17.10.23
17.10.23
3.46%
29.10.22
29.10.22
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Innovative
Sustainability is very important
Adler Real Estate AG
Start price
Target price
Perf. (%)
€7.22
17.10.22
17.10.22
€8.00
17.10.23
17.10.23
-1.39%
20.03.23
20.03.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Sfc Energy AG
Start price
Target price
Perf. (%)
€16.70
17.10.22
17.10.22
€19.00
17.10.23
17.10.23
14.73%
18.10.23
18.10.23
Could be worthwhile Investment >10% per year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€3.84
17.10.22
17.10.22
-
17.10.23
17.10.23
40.63%
18.05.23
18.05.23
Risky Investment
Blue Apron Holdings Inc.
Start price
Target price
Perf. (%)
€26.90
17.10.22
17.10.22
€54.00
17.10.23
17.10.23
7.36%
02.11.22
02.11.22
Could be very worthwhile Investment >20% year
Copper Mountain Mining
Start price
Target price
Perf. (%)
€1.40
17.10.22
17.10.22
-
17.10.23
17.10.23
23.83%
18.10.23
18.10.23
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Future proof or reliable business model
Revenue growth >5% per year expected
ITM Power plc
Start price
Target price
Perf. (%)
€1.08
17.10.22
17.10.22
€2.00
17.10.23
17.10.23
-21.91%
18.10.23
18.10.23
Medium risks for its business
Innovative
Sustainability is important
Significant cyclical dependencies
Mag Silver Corp.
Start price
Target price
Perf. (%)
€12.89
17.10.22
17.10.22
-
17.10.23
17.10.23
-2.21%
30.01.23
30.01.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Jaguar Mining Inc.
Start price
Target price
Perf. (%)
€2.05
17.10.22
17.10.22
-
17.10.23
17.10.23
-4.87%
23.01.23
23.01.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Homology Medicines Inc
Start price
Target price
Perf. (%)
€1.31
16.10.22
16.10.22
-
16.10.23
16.10.23
-17.62%
27.12.22
27.12.22
Risky Investment
TCR2 Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.68
16.10.22
16.10.22
-
16.10.23
16.10.23
-6.83%
30.10.22
30.10.22
Could be very worthwhile Investment >20% year
Hypoport SE
Start price
Target price
Perf. (%)
€86.20
16.10.22
16.10.22
€90.00
16.10.23
16.10.23
-4.58%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
Energiekontor
Start price
Target price
Perf. (%)
€87.50
15.10.22
15.10.22
€95.00
15.10.23
15.10.23
-17.49%
16.10.23
16.10.23
Could be worthwhile Investment >10% per year
CropEnergies AG
Start price
Target price
Perf. (%)
€14.22
15.10.22
15.10.22
€15.50
15.10.23
15.10.23
6.75%
25.10.22
25.10.22
Could be worthwhile Investment >10% per year
Delignit AG
Start price
Target price
Perf. (%)
€5.10
15.10.22
15.10.22
€7.00
15.10.23
15.10.23
-17.25%
16.10.23
16.10.23
Could be worthwhile Investment >10% per year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.54
15.10.22
15.10.22
€2.00
15.10.23
15.10.23
-0.88%
29.10.22
29.10.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Banca Monte dei Paschi di Siena SpA
Start price
Target price
Perf. (%)
€2.05
15.10.22
15.10.22
€4.00
15.10.23
15.10.23
-4.85%
29.10.22
29.10.22
EBIT decline/stagnation expected
High valuation
negative Cash Flow expected
Business model of the past or high risk
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.63
14.10.22
14.10.22
€5.00
14.10.23
14.10.23
-84.59%
15.10.23
15.10.23
Could be worthwhile Investment >10% per year
B.R.A.I.N. Biotechnology Research and Information Network AG
Start price
Target price
Perf. (%)
€4.98
13.10.22
13.10.22
-
13.10.23
13.10.23
-18.27%
14.10.23
14.10.23
Novavax Inc.
Start price
Target price
Perf. (%)
€21.36
13.10.22
13.10.22
€20.00
13.10.23
13.10.23
-48.44%
11.01.23
11.01.23
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float